Related Experiment Video

Updated: May 9, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar Rhabdomyosarcoma

M Imran Aslam1, Simone Hettmer, Jinu Abraham

  • 1Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., MC-L321, Portland, OR 97239. keller@ohsu.edu.

Molecular Cancer Research : MCR
|August 10, 2013
PubMed
Abstract

Insights

Receptor tyrosine kinase (RTK) expression in alveolar rhabdomyosarcoma (aRMS) changes dynamically. Nuclear insulin-like growth factor-1 receptor (IGF-1R) promotes tumor growth and is a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Targeted therapies, including tyrosine kinase inhibitors (TKIs), have advanced cancer treatment.
  • Receptor tyrosine kinases (RTKs) play critical roles in cancer progression.
  • Rhabdomyosarcoma (RMS) requires novel therapeutic strategies, necessitating a deeper understanding of RTK heterogeneity.

Purpose of the Study:

  • To investigate the dynamic expression profiles of RTKs in alveolar RMS (aRMS).
  • To explore the role of platelet-derived growth factor receptor alpha (PDGFRα) and insulin-like growth factor-1 receptor (IGF-1R) in aRMS.
  • To determine the impact of RTK subcellular localization on tumor progression and therapeutic response.

Main Methods:

  • Utilized a transgenic mouse model of aRMS expressing PDGFRα and IGF-1R.
  • Employed fluorescence-activated cell sorting (FACS) to analyze RTK expression in sorted subpopulations.
  • Investigated the functional significance of IGF-1R using RNA interference (RNAi)-mediated gene silencing and assessed tumor formation in vivo.

Main Results:

  • Cell surface expression of PDGFRα and IGF-1R showed dynamic alterations in sorted aRMS subpopulations.
  • Nuclear localization of IGF-1R was conserved and correlated with more efficient tumor establishment in vivo.
  • Silencing IGF-1R significantly reduced anchorage-independent colony formation in aRMS cells with high IGF-1R expression.

Conclusions:

  • Dynamic changes in RTK expression and subcellular localization are crucial factors in aRMS progression.
  • Nuclear IGF-1R is a key driver of tumor growth and a potential therapeutic target in aRMS.
  • RTK expression status and localization dynamics are vital considerations for developing personalized medicine approaches in RMS.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

Published on: March 7, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...